Cosmetic cross-reference

Magnesium Salicylate

CAS 18917-89-0

Magnesium Salicylate (CAS 18917-89-0) is a pharmaceutical compound with 0 bioactivity targets and 3 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
3
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Magnesium Salicylate
CAS Number
18917-89-0
UNII
JQ69D454N1
InChIKey
MQHWFIOJQSCFNM-UHFFFAOYSA-L
ChEMBL ID
CHEMBL2106755
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE DrugCentral 3 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Broncholithiasis 10 77.43 10065037
Lymph node calcification 10 69.64 10056284
Bronchial wall thickening 10 51.568 10067182

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
Magnesium Salicylate 52364 SU MTHSPL
MAGNESIUM SALICYLATE 52364 SU MTHSPL
Magnesium salicylate 52364 SU MTHSPL
magnesium salicylate 52364 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Magnesium Salicylate used for in pharmaceutical contexts?

Magnesium Salicylate (CAS 18917-89-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Magnesium Salicylate?

Magnesium Salicylate has 3 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Broncholithiasis, Lymph node calcification, Bronchial wall thickening. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Magnesium Salicylate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Magnesium Salicylate with EU status "permitted".

What clinical phase is Magnesium Salicylate in?

No phase 1-4 clinical development badge is rendered for Magnesium Salicylate because the matched compound identifier rows do not contain a max-phase value.